Lane Simonian
Contributor since: 2015
Articles
Biogen's Important Year: Challenges To Tecfidera And Aducanumab
Tue, Jul. 28 BIIB50 Comments
How The FDA's Decision On Aducanumab May Affect The Value Of Biogen's Stock
Wed, Apr. 8 BIIB25 Comments
Anavex 2-73 And Neurological Disorders: A Possible Path Forward
Mon, Mar. 9 AVXL32 Comments
Biogen And Neurotrope: Why Numbers Cannot Overcome Alzheimer's Disease
Mon, Feb. 3 BIIB, NTRP37 Comments
Biogen And Eisai's Aducanumab And Green Valley's GV-971: A Contrasting Tale Of 2 Charts
Nov. 20, 2019 BIIB, ESALF12 Comments
Biogen And Eisai's Aducanumab: All That Glitters Is Not Gold
Nov. 4, 2019 BIIB, ESALF12 Comments
Biogen, Amyloid, And Alzheimer's Disease: Once More Down The Rabbit Hole
Oct. 24, 2019 BIIB39 Comments
Anavex, Glovia, And India Globalization Capital: The Future Of Alzheimer's Treatments
Sep. 25, 2019 AVXL15 Comments
Biohaven, Anavex, And Neurotrope: Addressing The Role Of Protein Kinase C In Alzheimer's Disease
Jun. 28, 2019 AVXL, BHVN, NTRP45 Comments
Pfizer And INmune Bio: Seeking The Blockade Of Tumor Necrosis Factor Alpha For Alzheimer's Disease
Jun. 24, 2019 INMB3 Comments
Biogen: The End Of The Amyloid Era For Alzheimer's Disease?
Mar. 26, 2019 BIIB15 Comments
Anavex 2-73 And Alzheimer's Disease: A Partial Picture
Mar. 13, 2019 AVXL27 Comments
Biohaven's Trigriluzole: A Contender In The Race To Treat Alzheimer's Disease?
Feb. 27, 2019 BHVN21 Comments
Roche, Biogen, And The Achilles' Heel Of Alzheimer's Drug Development
Feb. 4, 2019 BIIB, RHHBY8 Comments
Neurotrope And Alzheimer's Disease: A Placebo Problem Or A Placebo Solution?
Jan. 14, 2019 NTRP13 Comments
Alzheimer's Pathways: An Investor's Guide To Biogen, Anavex, And Neurotrope
Nov. 6, 2018 AVXL, BIIB, NTRP14 Comments
Biogen: One More Time Around The Alzheimer's Block
Oct. 29, 2018 BIIB10 Comments
Biogen Results: Time To Change The Paradigm In Alzheimer's Disease
Aug. 3, 2018 BIIB23 Comments
Biogen And Alzheimer's Disease: Reasons For Caution
Jul. 10, 2018 BIIB10 Comments
Alzheimer's Disease: A History Of Drug Failures
Jun. 19, 2018 AZN, LLY, MRK11 Comments
Anavex 2-73: Addressing The Causes Of Alzheimer's Disease
Jun. 5, 2018 AVXL23 Comments
Neurotrope And The Missing Step In Alzheimer's Disease
Mar. 13, 2018 NTRP13 Comments
Anavex 2-73 And The Stabilization Of Alzheimer's Disease
Mar. 12, 2018 AVXL28 Comments
Biogen, Neurotrope, Anavex And The Future Of Alzheimer's Treatments
Mar. 1, 2018 AVXL, BIB, NTRP32 Comments
Anavex And Alzheimer's Disease At The Crossroads
Jan. 30, 2018 AVXL34 Comments
The Curious Case Of Neurotrope
Jan. 18, 2018 NTRP24 Comments
Alzheimer's Disease: Anavex 2-73 And The Long Road Home
Nov. 8, 2017 AVXL66 Comments
Why The Anti-Amyloid Approach To Alzheimer's Disease Has Failed
Oct. 24, 2017 BIIB, LLY, MRK5 Comments
Alzheimer's Disease: A Case For Combination Therapy
Sep. 26, 2017 AXON-OLD7 Comments
Alzheimer's Disease: 40 Years In The Wilderness
May 10, 2017 AXON-OLD, BIIB2 Comments
Neurotrope: Lessons Learned
May 4, 2017 NTRP56 Comments
Alzheimer's Disease: What's Next?
Mar. 13, 2017 AVXL18 Comments